ARTICLE | Clinical News
CPP-115 regulatory update
September 27, 2010 7:00 AM UTC
FDA granted Orphan Drug designation for Catalyst's CPP-115 to treat infantile spasms. The company plans to submit an IND next half for the GABA transaminase inhibitor. ...